Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT01982097 · COMPLETED

Trial details

NCT number: NCT01982097
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Renal Cell

Start date: 2014-01-10
Primary completion: 2017-01-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.